Applicability of the lung immune prognostic index (LIPI) in patients with metastatic solid tumors when treated with immune checkpoint inhibitors (ICI) in early clinical trials

被引：0
|
作者：
Varga, A. [1 ]
Bernard-Tessier, A. [2 ]
Auclin, E. [3 ]
Perez, L. Mezquita [2 ]
Baldini, C. [1 ]
Planchard, D. [2 ]
Marabelle, A. [1 ]
Hollebecque, A. [1 ]
Besse, B. [2 ]
Massard, C. [1 ]
机构：
[1] Gustave Roussy Canc Campus, Drug Dev Dept, Villejuif, France
[2] Gustave Roussy Canc Campus, Dept Canc Med, Villejuif, France
[3] Hop European George Pompidou, Oncol, Paris, France
来源：
ANNALS OF ONCOLOGY | 2019年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3O
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Neurologic immune related adverse events (irAEs) in patients with metastatic solid tumors treated with immune checkpoint inhibitors: a single institution retrospective analysis
    Malani, Rachna
    Haggiagi, Aya
    Holder, Jenessa
    Shames, Yelena
    Briggs, Samuel
    Callahan, Margaret
    Santomasso, Bianca
    NEUROLOGY, 2018, 90
  • [42] Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors
    Chester Kao
    Soren Charmsaz
    Hua-Ling Tsai
    Khaled Aziz
    Daniel H. Shu
    Kabeer Munjal
    Ervin Griffin
    James M. Leatherman
    Evan J. Lipson
    Yasser Ged
    Jeannie Hoffman-Censits
    Howard L. Li
    Elsa Hallab
    Madelena Brancati
    Mari Nakazawa
    Stephanie Alden
    Christopher Thoburn
    Nicole E. Gross
    Alexei G. Hernandez
    Erin M. Coyne
    Emma Kartalia
    Marina Baretti
    Elizabeth M. Jaffee
    Sanjay Bansal
    Laura Tang
    G. Scott Chandler
    Rajat Mohindra
    Won Jin Ho
    Mark Yarchoan
    Daniel J. Zabransky
    Nature Communications, 16 (1)
  • [43] Outcomes of Lynch syndrome (LS) patients treated with immune checkpoint inhibitors (ICI).
    Bari, Shahla
    Kim, Richard D.
    Wang, Xia
    Matejcic, Marco
    Muzaffar, Jameel
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [44] Letter comments on: Validation of the Lung Immune Prognostic Index (LIPI) as a prognostic biomarker in metastatic renal cell carcinoma
    Rebuzzi, Sara Elena
    Fornarini, Giuseppe
    Banna, Giuseppe Luigi
    Rescigno, Pasquale
    Buti, Sebastiano
    EUROPEAN JOURNAL OF CANCER, 2024, 205
  • [45] Real-world outcomes of patients (pts) with malignant solid tumors treated with immune checkpoint inhibitors (ICI) in relation to smoking status
    El Saadany, T.
    Petrausch, U.
    Mora, A. R.
    Renner, C.
    Winder, T.
    Benda, M.
    Reimann, P.
    Jakob, A.
    Daza, A. C.
    Mueller, G.
    von Moos, R.
    Mark, M.
    SWISS MEDICAL WEEKLY, 2023, 153 : 24S - 24S
  • [46] Prognosis stratification of cancer patients treated with immune checkpoint inhibitors through lung immune prognostic index: a meta-analysis and systematic review
    Guo, Yusheng
    Pan, Yao
    Wan, Jiayu
    Gong, Bingxin
    Li, Yi
    Kan, Xuefeng
    Zheng, Chuansheng
    BMC CANCER, 2024, 24 (01)
  • [47] Clinical evidence for the prognostic impact of metformin in cancer patients treated with immune checkpoint inhibitors
    Shen, Jinhai
    Ye, Xinqi
    Hou, Hui
    Wang, Yun
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2024, 134
  • [48] Vitiligo is correlated with clinical benefits in patients with advanced cutaneous melanoma treated with immune checkpoint inhibitors (ICI).
    Reinas, Gaston Martin
    Muino, Marcelo
    Abal, Mariana
    Gerardi, Carlos Garcia
    Tognelli, Flavio
    Deza, Ernesto Gil
    Gonzalez, Cesar
    Gonzalez, Liliana D.
    Nunell, Marcelo Andres
    Ordonez, Alba Marin
    Morgenfeld, Eduardo L.
    Rivarola, Edgardo G. J.
    Gercovich, Felipe G.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [49] Clinical outcomes of EGFR plus NSCLC pts treated with immune checkpoint inhibitors (ICI).
    Piotrowska, Zofia
    Cobb, Rosemary G.
    Banwait, Mandeep
    Marcoux, Nicolas
    Mooradian, Meghan
    Dagogo-Jack, Ibiayi
    Lin, Jessica Jiyeong
    Heist, Rebecca Suk
    Shaw, Alice Tsang
    Gainor, Justin F.
    Sequist, Lecia V.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [50] Clinical outcomes and safety of immune checkpoint inhibitors in patients with solid tumors and paraneoplastic syndromes
    Nassar, Amin H.
    El Zarif, Talal
    Khalid, Ahmed Bilal
    Rahme, Serena
    Zhong, Caiwei
    Kwak, Lucia
    Salame, Marita
    Farhat, Elias Bou
    Freeman, Dory
    El-Am, Edward
    Ravishankar, Arjun
    Ahmad, Bachar
    Nana, Frank Aboubakar
    Kaldas, David
    Naqash, Abdul Rafeh
    Sharon, Elad
    LeBoeuf, Nicole R.
    Cortellini, Alessio
    Malgeri, Andrea
    Gupta, Shruti
    Al-Hader, Ahmad
    Sparks, Jeffrey A.
    Linnoila, Jenny
    Hamnvik, Ole-Petter R.
    Mouhieddine, Tarek H.
    Marron, Thomas
    Parikh, Kaushal
    McKay, Rana R.
    Dilling, Thomas
    Choueiri, Toni K.
    Adib, Elio
    Najem, Elie
    Kim, So Yeon
    Sonpavde, Guru
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2024, 12 (03)
12345